Skip to content

Comparison of ozone effect on knee osteoarthritis

Comparison the therapeutic effect of one-time with three-times ozone injection under ultrasound guidance in patients with knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151017024572N18
Enrollment
40
Registered
2018-09-01
Start date
2018-09-11
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primery gonrthrosis,bilatral. Bilateral primary osteoarthritis of knee

Interventions

Intervention 1: Intervent group: three times ozon injectione with a one-week interval by a physician and rhabilition spesialist under the ultrasound guide in the knee joint through a supra patellar

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with mild to moderate OA of the knee (Kellgren Lawrence grade I, II and III) Knee pain for at least six months Age 40 to 75 years old The absence of any acute or chronic infection No pregnancy or lack of planning to get pregnant No history of any intra articular knee injection in three months ago The absence of inflammatory articular disease or secondary osteoarthritis No history of knee surgery (3 months ago) No severe underlying disease such as uncontrolled diabetes Use of anticoagulants Lack of daily use of opioid and non opioid analgesics Absence of contraindications of ozone therapy (deficiency G6PD, uncontrolled hyperthyroidism, leukemia).

Exclusion criteria

Exclusion criteria: The willingness of patients to exit from the study at any stage of the study Not coming patients for follow up and evaluation during the follow up period Daily use of any type of analgesic medication by patients during the follow up period Occurring a pathology in the knee, such as meniscus tear during the follow up period Occurring 4th and 7th inclusion criteria, during the study.

Design outcomes

Primary

MeasureTime frame
The severity of pain. Timepoint: Zero, one, four and twelve weeks after. Method of measurement: Visual Analog Scale(VAS).;The severity of symptoms and functional limitations. Timepoint: Zero, one, four and twelve weeks after. Method of measurement: By using WOMAC questioner.;Sonographic criteria (efusion). Timepoint: Zero, one, four and twelve weeks after. Method of measurement: By using sonographic device.;Range of motion. Timepoint: Zero, one, four and twelve weeks after. Method of measurement: Goniometer.;Side effects. Timepoint: one, four weeks after. Method of measurement: Physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Vajihe Alishahi

Iran University of Medical Sciences

vajihe.alishahi@yahoo.com+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026